Fresenius | FRE - Selling And Administration Expenses

Stock Price
48.61
Daily Change
0.65 1.36%
Monthly
1.93%
Yearly
31.66%
Q1 Forecast
45.82

Fresenius reported EUR676M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Akzo Nobel EUR 783M 43M Sep/2025
Alcon AG USD 865M 5M Sep/2025
AstraZeneca USD 148M 4.86B Sep/2025
BASF EUR 2.2B 384M Sep/2025
Bayer EUR 3.4B 140M Sep/2025
Beiersdorf EUR 322M 1.68B Jun/2025
DaVita Healthcare Partners USD 414.37M 1.57M Sep/2025
Demant DKK 5.95B 319M Jun/2025
E.ON EUR -1.71B 3.63B Jun/2025
Essilor EUR 1.09B 2.08B Jun/2025
Fresenius EUR 676M 64M Sep/2025
Fresenius Medical Care EUR 705.44M 86.56M Sep/2025
Getinge SEK 2.65B 452M Dec/2024
Givaudan CHF 294.5M 229.5M Jun/2024
GlaxoSmithKline GBP 2.16B 19M Sep/2025
GN Store Nord DKK 1.41B 8M Sep/2025
GRIFOLS EUR 284.99M 2.24M Sep/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Merck EUR 1.46B 16M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Philips EUR 1.18B 61M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
RWE EUR 690M 84M Mar/2025
Sanofi EUR 2.75B 455M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025